ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
SELLAS Life Sciences Group Inc

SELLAS Life Sciences Group Inc (SLS)

1.46
-0.06
(-3.95%)
At close: April 26 4:00PM
1.47
-0.05
( -3.29% )
After Hours: 6:07PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.47
Bid
1.44
Ask
1.47
Volume
1,287,058
1.4217 Day's Range 1.545
0.4986 52 Week Range 1.914
Market Cap
Previous Close
1.52
Open
1.53
Last Trade Time
18:07:36
Financial Volume
$ 1,894,328
VWAP
1.4718
Average Volume (3m)
1,400,092
Shares Outstanding
32,062,258
Dividend Yield
-
PE Ratio
-1.25
Earnings Per Share (EPS)
-1.16
Revenue
-
Net Profit
-37.34M

About SELLAS Life Sciences Group Inc

SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
SELLAS Life Sciences Group Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SLS. The last closing price for SELLAS Life Sciences was $1.52. Over the last year, SELLAS Life Sciences shares have traded in a share price range of $ 0.4986 to $ 1.914.

SELLAS Life Sciences currently has 32,062,258 shares outstanding. The market capitalization of SELLAS Life Sciences is $46.49 million. SELLAS Life Sciences has a price to earnings ratio (PE ratio) of -1.25.

SLS Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.07-4.545454545451.541.721.421714696881.56092947CS
40.4442.71844660191.031.720.97514620091.39217462CS
120.8852151.3679890560.58481.720.559514000921.1606053CS
260.5763.33333333330.91.720.498611887651.00202719CS
520.0751.41.9140.49867105361.07030131CS
156-6.77-82.16019417488.2415.07890.49864303333.18055482CS
2600.5559.78260869570.9219.380.1124020481.97303117CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FLJFLJ Group Limited
$ 0.6589
(19.80%)
1.29M
SBETSharpLink Gaming Inc
$ 1.17
(12.49%)
2.43k
BRFHBarfresh Food Group Inc
$ 1.56
(10.64%)
17.73k
LINKInterlink Electronics Inc
$ 6.11
(9.89%)
208
DFLIDragonfly Energy Holdings Corporation
$ 0.845
(9.85%)
4.43k
CLVRClever Leaves Holdings Inc
$ 1.35
(-67.15%)
142.75k
FCUVFocus Universal Inc
$ 0.2879
(-10.67%)
242.02k
GNTAGenenta Science SPA
$ 2.35
(-9.27%)
3.03k
BDRXBiodexa Pharmaceuticals PLC
$ 1.18
(-9.23%)
823.71k
CACOCaravelle International Group
$ 0.9079
(-9.21%)
94.38k
IVPInspire Veterinary Partners Inc
$ 0.0435
(-1.14%)
13.06M
PEGYPineapple Energy Inc
$ 0.0626
(0.00%)
3.94M
BRSHBruush Oral Care Inc
$ 0.062
(5.08%)
3.49M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0478
(1.70%)
3.17M
SQQQProShares UltraPro Short QQQ
$ 11.43
(0.00%)
3M

SLS Discussion

View Posts
govprs govprs 2 weeks ago
Yahoo finance add sls and review of the conversations tab.
πŸ‘οΈ0
peterus peterus 2 weeks ago
you have a link ?
πŸ‘οΈ0
govprs govprs 3 weeks ago
On yahoo they are talking 4 min.
πŸ‘οΈ0
harry crumb harry crumb 4 weeks ago
Agree, might see 1.70’s again, worth the risk with a stop limit on shares purchased at 1$ or more
👍️ 1
peterus peterus 4 weeks ago
ok thanks
πŸ‘οΈ0
TTsr TTsr 4 weeks ago
I believe it’s gonna before EOM… pr stated idmc scheduled β€˜by’ EOM…
πŸ‘οΈ0
peterus peterus 4 weeks ago
yup think next month data phase3 end april ... should see 1.50s before data
πŸ‘οΈ0
harry crumb harry crumb 1 month ago
Maybe another pop to 1.60
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
SLS 10Q due 3/22
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
SLS under $2
πŸ‘οΈ0
harry crumb harry crumb 2 months ago
Hit an run with this one
👍️ 1
harry crumb harry crumb 3 months ago
No way, lotto play here. This is nothing but risk
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 3 months ago
Let’s go $$$$$ reeling $$$$$$
πŸ‘οΈ0
harry crumb harry crumb 4 months ago
Junk
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
SLS new 52 week low
πŸ‘οΈ0
willlbone willlbone 4 months ago
And Dilution.
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 4 months ago
Merry Christmas $$$$$
πŸ‘οΈ0
harry crumb harry crumb 4 months ago
Doubt it, insiders just sold shares!
πŸ‘οΈ0
drkazmd65 drkazmd65 4 months ago
Rumor mill over on Stocktwits is that STELLAS is about to receive Orphan Drug status for their T-cell lymphoma treatment. No PR out yet but,.... Dated today,...

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=977523
👍️ 1
harry crumb harry crumb 6 months ago
Climbing back up
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
SLS new 52 week low
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 7 months ago
Sex always makes money! Lol
πŸ‘οΈ0
weedtrader420 weedtrader420 7 months ago
SLS FDA NEWS WOOHOOOOOO WOOHOOOOOO
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
SLS under $2
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
After that dilution it’l double in price, always does
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Breakout coming, this science could be a game changer
πŸ‘οΈ0
TTsr TTsr 1 year ago
Fingers crossed! Still an unknown, to us, but after the first IDMC & positive sentiment from Tuesday’s KOL TC it’s hard to imagine GPS not achieving its P3 primary endpoints!
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
News coming? It’s rippn
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
3.09 trade! Lmao, mm’s will do anything to get cheapies. This ticker could be a huge play moving forwsrd $$$
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Going to 4
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Added to the stash
πŸ‘οΈ0
TTsr TTsr 1 year ago
β€œFollowing a prespecified review of unblinded data by the IDMC in accordance with its charter, its recommendation to continue the REGAL study as is, and with trial conduct and integrity intact, is outstanding news.” This quote was from the Sellas PR… does any know when the next β€˜schedule’ IDMC review is? Or is that info not available to the public?
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Back in today for the ride
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Wow glad we sold, held a few free ones, big hit today on the PR
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Any thoughts here moving forward, still up over 100% from those lows a few weeks ago.
πŸ‘οΈ0
harry crumb harry crumb 1 year ago
Sls looking good from 2$ range! $$$$
πŸ‘οΈ0
crudeoil24 crudeoil24 2 years ago
The update call on its Phase 3 REGAL clinical trial of galinpepimut-S (GPS) in patients with acute myeloid leukemia (AML) is on November 14, 2022.


The call will be facilitated by SELLAS management, including SELLAS' President and CEO, Angelos Stergiou, MD, ScD h.c., and Senior Vice President, Clinical Development, Dragan Cicic, MD, who will be joined by leading cancer researcher, M. Yair Levy, M.D., Director of Hematologic Malignancies Research at the Baylor University Medical Center, and member of the REGAL Steering Committee. Further details regarding how to access the update call will be provided in the coming weeks.
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Phase 3 update call news. A flop?? Who knows
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Time to get in again
πŸ‘οΈ0
CarlCarlMcB CarlCarlMcB 2 years ago
Ding ding ding we got a winner $$$$$$$$
Let it rain $$$$$$$$$
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Wonderful time to load an just sit-on them, could be a 10 bagger with patience
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Buy 20k wirth at 3.75 an u just made a quick 1500.00 flipping it in less than an hour! $$$$$
Trade it do not get married to this stock
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
That said, u can still make money on pumps an play the short position when needed.
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Agree, they don't care about traders an investors. Management just takes their salaries an bonus' an class a shares an runs with it, its just how it is. Offer more shares, dilute, RS to clean everything up
πŸ‘οΈ0
dinogreeves dinogreeves 2 years ago
These guys have been rampant with offerings since inception and reverse split and all rinse and repeat all the time.
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 years ago
https://ih.advfn.com/stock-market/NASDAQ/sellas-life-sciences-SLS/stock-news/87723555/sellas-life-sciences-announces-pricing-of-25-0-mi
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Ouch! Might take a position here at these prices
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
C where she goes
πŸ‘οΈ0
harry crumb harry crumb 2 years ago
Yeah we'l see. Positive buying today it seems
πŸ‘οΈ0
tknuncle tknuncle 2 years ago
You take that back harry!!! I sure hope you are wrong with that prediction lol. I feel like SLS has HUGE potential and we will see a much higher PPS later this year. I might be wrong as well but only time will tell. Best of luck to you buddy :)
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock